AGP Picks
View all

Entertainment Wire Massachusetts: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Entertainment Wire Massachusetts.

Press releases published on October 27, 2026

Mothballed Mills and Historic Mine Sites Move Back Into Silver’s Plans
beehiiv Launches Podcast Advertising Tools for Creators of All Sizes
Idea Grove Named One of Inc.'s Best Power Partners in the United States
Salem Radio Network to Launch “Hollywood 360” on November 30, Bringing Hollywood’s Golden Age of Radio to Stations Nationwide
Ahead of a January 2027 Pentagon Sourcing Rule, Tungsten Projects Outside China Move Into Permits and Restarts
Rocket Software Selects 23 Projects to Compete at Rocket.Build 2026 Finals in London
Microbot Medical® Secures its First Office-Based Lab (OBL) Customer for the LIBERTY® Endovascular Robotic System
Candel Therapeutics to Present at November Investor Conferences
Voyager’s Tau-Targeted Gene Therapy VY1706 and Anti-Tau Antibody VY7523 for Alzheimer’s Disease to Be Featured in Poster Presentations at CTAD 2026
Forge Acquires Kisaco Research, Adding AI Infra Summit and a Portfolio of High-Growth Specialist Events
CAMP4 Therapeutics Receives Clinical Trial Application Approval for Phase 1/2 Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder in the European Union
Luva Debuts Revolutionary AI-Powered Insurance Comparison Platform
Wave Life Sciences Reports Third Quarter 2026 Financial Results and Provides Business Update
Vertero Completes Patient Enrollment in Phase 1b Clinical Study of VT-5006 – an Investigational Treatment for Parkinson’s Disease
Stellar Pictures Showcases Premium Productions at MIPCOM Cannes, Bringing Eastern Aesthetics to Global Audiences
Presenting on Emerging Growth Conference 97 Day 1 on October 28; Register to live stream
Cullinan Therapeutics Advances Velinotamig into Global Clinical Development for Autoimmune Cytopenias Following IND Clearance by the U.S. FDA
Factorial Sets Date for Third Quarter 2026 Results
Beam Therapeutics Reports Initial Clinical Data from Phase 1/2 Trial of BEAM-301, Demonstrating Proof of Concept for Genetic Correction in Glycogen Storage Disease Type Ia (GSDIa) at ESGCT 33rd Annual Congress
Marathon Feet Trace China Tianjin's Stories as 30,000 Runners Hit the Streets

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Entertainment Wire Massachusetts

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.